Warning: Undefined variable $page_cluster_id in /home3/thegood9/public_html/website_70aad9ea/header.php on line 29



Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 61

Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 77

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Tag Directory / PUBLICHEALTH     showing 201–220 of 358   RSS



Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 161

What to Expect at the World Cancer Congress 2026 – UICC

oncodaily - Union for International Cancer Control (UICC) shared a post on LinkedIn: “The preliminary program for the World Cancer Congress 2026 – taking place in Hong Kong and hosted by UICC […]

AI Summary: The Union for International Cancer Control released the preliminary program for World Cancer Congress 2026, outlining sessions on prevention, equity, innovation and global collaboration. The meeting will assemble policymakers, clinicians and advocates to debate strategy and share research—expect plenaries, networking and ambitious goals paired with painfully realistic budgets.


Cutting-edge research: enzymes, AI, biomarkers transforming cancer care

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / medicalxpress

3 months / oncodaily

3 months / esmo

3 months / sciencedaily

3 months / nature

3 months / nature


Global oncology meetings: convening leaders and reviewers worldwide

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily


Other: market, jobs, commentary, and patient communication

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily


Previewing World Cancer Congress 2026: program, goals, real budgets

3 months / oncodaily


All Other Stories

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / esmo

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / esmo

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / medicalxpress

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / esmo

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / esmo

3 months / oncodaily

3 months / nature

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / targetedonc

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / sciencedaily

3 months / esmo

3 months / nature

3 months / nature

3 months / nature



Destructive meningitis cases raise concerns about emerging pathogen

medicalxpress - Penn State College of Medicine is reporting on two cases of destructive infant meningitis linked to Paenibacillus infection, documenting severe neurologic injury and raising concerns about diagnosis and treatment. Reports from Uganda first linked these or…

AI Summary: Penn State researchers reported two infants who developed severe, often destructive, meningitis linked to Paenibacillus infection. The rare cases resulted in serious outcomes and prompted clinical and public‑health scrutiny of an uncommon pathogen, highlighting diagnostic challenges and the need for heightened awareness among clinicians and investigators.

#healthcare #publichealth #infanthealth

3 months / medicalxpress


Back to Top / Monday, February 16, 2026, 12:21 am / permalink 19222 / 2 stories in 3 months /

Intermittent fasting probably doesn’t help with weight loss

newscientist - Intermittent fasting appears to be no better than doing nothing when it comes to helping people who are overweight or have obesity lose weight

AI Summary: Large-scale reviews and new analyses find intermittent‑fasting regimens deliver weight‑loss results comparable to standard dietary advice or doing nothing special. The evidence undercuts the popular hype: fasting patterns don’t reliably outperform conventional approaches, and benefits often reflect overall calorie reduction rather than any magic timing effect.

#obesity #healthcare #weightloss #publichealth

3 months / bbc

3 months / newscientist

3 months / medicalxpress


Back to Top / Monday, February 16, 2026, 12:21 am / permalink 19221 / 4 stories in 3 months /

Can medical AI lie? Large study maps how LLMs handle health misinformation

medicalxpress - Medical artificial intelligence (AI) is often described as a way to make patient care safer by helping clinicians manage information. A new study by the Icahn School of Medicine at Mount Sinai and collaborators confronts a critical vulnerability: when a m…

AI Summary: A broad analysis — including Mount Sinai research — shows large language models and medical AI systems can propagate false or misleading health claims when presented in realistic clinical language. Findings expose safety gaps, underline risks of unchecked deployment, and call for tighter guardrails, validation and clinician oversight before clinical use.

#healthcare #publichealth #governmentpolicy #fda #digitalhealth #medicaldevices

3 months / medicalxpress

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / discovermagazine

3 months / medicalxpress

3 months / oncodaily

3 months / medicalxpress

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / medicalxpress


Back to Top / Saturday, February 14, 2026, 3:21 pm / permalink 19202 / 35 stories in 3 months /

Physicians are not 'providers': New paper says names in health care have ethical significance

medicalxpress - A new ethics policy paper from the American College of Physicians (ACP) says the term "provider" should not be used to describe physicians, and using the blanket term undermines physicians' ethical responsibility, clinical integrity, and professionalism.

AI Summary: A new ethics paper contends that referring to doctors as “providers” erodes professional accountability and the ethical obligations central to medicine. Coverage highlights concerns that terminology matters for trust, clinical integrity and patient relationships, prompting debate about language use across health systems and policy forums.

#healthcare #publichealth #governmentpolicy

3 months / healthcaredive

3 months / medicalxpress


Back to Top / Saturday, February 14, 2026, 3:21 pm / permalink 19201 / 6 stories in 3 months /

Physicians push back on Alabama robotic ultrasound proposal

Mariah Taylor / beckershospitalreview - Alabama’s proposal to use robotic ultrasounds to close care gaps is being praised by national leaders but facing pushback from local physicians, KFF Health News reported Feb. 12. Alabama is facing above national average rates for infant mortality on top o…

AI Summary: Alabama’s plan to expand robotics in maternity services — including proposals for robotic ultrasounds and other automation — has provoked physician backlash. Clinicians warn that substituting machines for bedside assessment could erode accountability and patient safety in a state already wrestling with poor maternal outcomes, triggering a heated debate about technology versus hands‑on care.

#healthcare #publichealth #governmentpolicy #infanthealth #digitalhealth #medicaldevices

3 months / medicalxpress

3 months / medicalxpress

3 months / livescience

3 months / medicalxpress


Back to Top / Saturday, February 14, 2026, 2:21 pm / permalink 19199 / 8 stories in 3 months /

Lilly appeals retatrutide classification ruling in case that could impact compounders

Alexis Kramer / endpoints - Eli Lilly is challenging a decision over how the FDA classified its experimental, next-gen obesity shot, in a case that could affect the ability of compounders to rival it. On Thursday, Lilly filed a notice ...

AI Summary: Eli Lilly is contesting a regulatory classification decision for its next‑generation obesity shot while simultaneously stockpiling doses ahead of potential U.S. approval. The dispute has broader implications for compounding pharmacies and has coincided with lawsuits accusing telehealth vendors and compounders of selling unapproved oral GLP‑1 alternatives — a messy intersection of commerce, regulation and patient safety.

#obesity #healthcare #pharmaceuticals #elililly #weightloss #publichealth #drugdevelopment #fda #digitalhealth

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / bbc

3 months / medicalxpress

3 months / discovermagazine

3 months / medicalxpress

3 months / medicalxpress

3 months / fiercehealthcare


Back to Top / Saturday, February 14, 2026, 12:21 pm / permalink 19191 / 15 stories in 3 months /

Extracorporeal liver cross-circulation using transgenic xenogeneic pig livers with brain-dead human decedents

Abraham Shaked / nature - Nature Medicine, Published online: 09 February 2026; doi:10.1038/s41591-025-04196-3In a study of four brain-dead human decedents, extracorporeal liver cross-circulation using genetically modified pig livers provides essential hepatic functions, supporting…

AI Summary: In a controversial translational study investigators ran blood between genetically modified pig livers and brain‑dead human decedents using an extracorporeal cross‑circulation system to assess organ viability and function. The work explores a potential bridge to expand transplantable organs, laying technical groundwork while prompting ethical and regulatory questions about next steps.

#healthcare #publichealth #governmentpolicy #biotech #fda #medicaldevices

3 months / medicalxpress

3 months / nature

3 months / medicalxpress


Back to Top / Saturday, February 14, 2026, 10:21 am / permalink 19188 / 4 stories in 3 months /

New FDA-Approved Device Uses Electric Fields to Treat Pancreatic Cancer

discovermagazine - Learn more about the newly approved wearable treatment that disrupts pancreatic cancer tumor growth while letting patients continue daily life at home.

AI Summary: The FDA approved a wearable device that delivers alternating electric fields to disrupt pancreatic tumor growth, letting patients remain ambulatory while receiving treatment. Clinicians hail the noninvasive approach as a new adjunct to standard care, aiming to slow progression in a cancer that’s notoriously hard to treat — and yes, it literally plugs into hope.

#healthcare #publichealth #biotech #fda #digitalhealth #medicaldevices #oncology #pancreaticcancer

3 months / oncodaily

3 months / medicalxpress

3 months / medicalxpress

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / sciencedaily

3 months / discovermagazine

3 months / oncodaily

3 months / oncodaily


Back to Top / Saturday, February 14, 2026, 10:21 am / permalink 19187 / 12 stories in 3 months /

HPV cancer vaccine slows tumor growth and extends survival in preclinical model

medicalxpress - Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not only on vaccine components but also on vaccine structure. After proving this concept across multiple studies, the…

AI Summary: A therapeutic HPV vaccine showed tumor shrinkage and longer survival in preclinical models of HPV‑driven oropharyngeal cancer, suggesting a possible adjunct to surgery and chemo‑radiation. Researchers say the approach could boost anti‑tumor immunity and inform next‑stage trials, though human efficacy and safety await clinical proof.

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment

3 months / sciencedaily

3 months / medicalxpress

3 months / medicalxpress

3 months / livescience

3 months / medicalxpress


Back to Top / Saturday, February 14, 2026, 5:21 am / permalink 19182 / 5 stories in 3 months /

FDA clears 1st blood test for Alzheimer’s in primary care

Ella Jeffries / beckershospitalreview - The first FDA-cleared blood test to assess Alzheimer’s disease in primary care is now available for patients age 55 and older with symptoms of cognitive decline. The test aims to help clinicians rule out Alzheimer’s by identifying individuals unlikely to …

AI Summary: Regulators cleared the first blood test for Alzheimer’s for primary‑care use while researchers published capillary sampling methods and analyses showing blood biomarkers’ promise for dementia diagnosis. Together these developments push biomarker testing out of specialty clinics and toward routine care — promising earlier detection, though concerns about population diversity, accuracy thresholds and rollout logistics remain.

#healthcare #publichealth #governmentpolicy #biotech #fda

3 months / medicalxpress

3 months / medicalxpress

3 months / sciencedaily

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / nature

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / nature


Back to Top / Saturday, February 14, 2026, 4:21 am / permalink 19180 / 18 stories in 3 months /

Studies test whether gene-editing can fix high cholesterol. For now, take your medicine

medicalxpress - Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol.

AI Summary: Researchers are testing gene‑editing approaches aimed at providing a single‑procedure solution for elevated LDL cholesterol. Early human studies probe safety and durability, but experts urge patients to continue proven lipid‑lowering therapies for now. The line between ambitious science and everyday clinical care remains prudently guarded.

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment

3 months / medicalxpress

3 months / sciencedaily

3 months / go

3 months / medicalxpress


Back to Top / Saturday, February 14, 2026, 3:21 am / permalink 19179 / 4 stories in 3 months /

FDA to reassess the safety of BHA, a preservative used in popular snack foods

go - Federal health officials will reassess the safety of a chemical called BHA used in foods including potato chips, cereals, frozen meals and meat products

AI Summary: U.S. regulators have moved to reevaluate butylated hydroxyanisole (BHA), a common food preservative, ordering a fresh safety review after mounting evidence and public concern. The reassessment could lead to updated guidance or restrictions — which will delight activists and mildly inconvenience snack manufacturers.

#healthcare #publichealth #governmentpolicy #fda #foodsafety

3 months / medicalxpress

3 months / medicalxpress

3 months / go

3 months / medicalxpress


Back to Top / Saturday, February 14, 2026, 1:21 am / permalink 19176 / 4 stories in 3 months /

Report reveals a significant global palliative care gap among children

medicalxpress - Nearly all the world's 10.6 million children experiencing serious health-related suffering (SHS) live in low- and middle-income countries with little to no access to palliative care or specialized care for their illness, according to a comprehensive new r…

AI Summary: A new global analysis reveals roughly 10.6 million children live with serious health‑related suffering and face a striking lack of pediatric palliative services, especially in low‑ and middle‑income countries. The study calls for urgent policy, training and resource commitments to close the gap and reduce needless pain for sick children — because saying “we’ll do better” is no longer enough.

#healthcare #publichealth #governmentpolicy #infanthealth

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress


Back to Top / Saturday, February 14, 2026, 1:21 am / permalink 19175 / 13 stories in 3 months /

Ama launches independent vaccine review after CDC criticism

medicalxpress - Two major medical groups will begin reviewing vaccine safety and effectiveness after major changes at the U.S. Centers for Disease Control and Prevention (CDC) have raised alarms among experts.

AI Summary: The American Medical Association announced an independent review of vaccine safety and effectiveness in response to recent CDC changes and criticism, partnering with external researchers to evaluate evidence and restore public trust. The panel aims to provide transparent, expert analysis free of political noise.

#healthcare #pharmaceuticals #publichealth #governmentpolicy #cdc #vaccinesafety

3 months / livescience

3 months / sciencedaily

3 months / medicalxpress


Back to Top / Saturday, February 14, 2026, 12:22 am / permalink 19173 / 4 stories in 3 months /

Talkiatry Rakes In $210M to Scale Virtual Psychiatry Group

Katie Adams / medcitynews - Telepsychiatry provider Talkiatry has raised a $210 million Series D round led by Perceptive Advisors, bringing its total funding to more than $400 million. CEO Robert Krayn said the company is focused on scaling its clinician-employed model and improving…

AI Summary: Talkiatry closed a $210 million Series D led by Perceptive Advisors to scale its virtual psychiatry platform, expanding telepsychiatry access and accelerating growth plans. The financing positions the company to beef up operations, hire talent, and deepen partnerships as demand for remote mental health care surges.

#healthcare #publichealth #digitalhealth

3 months / medicalxpress

3 months / fiercehealthcare


Back to Top / Saturday, February 14, 2026, 12:22 am / permalink 19170 / 3 stories in 3 months /

AbbVie sues over selection of Botox for IRA negotiations

Nicole DeFeudis / endpoints - AbbVie is suing CMS for picking Botox for the third round of Medicare negotiations, making it the first drugmaker to challenge the upcoming cycle in court. In a lawsuit filed Wednesday in Washington, DC, AbbVie ...

AI Summary: AbbVie has filed suit challenging the federal decision to include Botox in Medicare’s drug price negotiation program, arguing the selection process was flawed and that the move could imperil innovation and pricing strategies. The lawsuit seeks to block or alter implementation while the industry and regulators brace for legal precedent.

#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy

Back to Top / Saturday, February 14, 2026, 12:22 am / permalink 19169 / 2 stories in 3 months /

Kaiser Permanente, DoL reach settlement over mental health access

fiercehealthcare - Kaiser Foundation Health Plan has agreed to a settlement with the Department of Labor that resolves multiple investigations into access for mental health and substance abuse services.

AI Summary: Kaiser Foundation Health Plan reached a settlement with the U.S. Department of Labor resolving investigations into alleged failures to provide adequate mental‑health access. The move comes amid rolling labor actions at Kaiser — pharmacy and lab employees briefly struck and later stood down while nurse‑led walkouts continued — exposing labor tensions and regulatory pressure.

#healthcare #publichealth #governmentpolicy

3 months / fiercehealthcare


Back to Top / Friday, February 13, 2026, 10:22 pm / permalink 19160 / 4 stories in 3 months /

Thousands of NYC nurses return to work, but one major strike goes on

medicalxpress - A monthlong nurses strike in New York City is coming to an end, but not for everyone.

AI Summary: After weeks of labor turmoil, most striking New York City nurses have tentatively returned under new agreements, but a substantial contingent at a major hospital remains on strike. Patients and families report care disruptions and uncertainty as remaining negotiations continue, highlighting strain on hospitals and lingering tensions between staff and management.

#healthcare #publichealth

3 months / medicalxpress

3 months / go


Back to Top / Friday, February 13, 2026, 6:22 pm / permalink 19158 / 4 stories in 3 months /

500M records exchanged through TEFCA, federal health IT office boasts

fiercehealthcare - At the 2026 Annual Meeting for the health IT office at HHS, officials announced a massive spike in the number of health records shared through the government-backed TEFCA initiative. The number seems to reflect the heavy focus Trump's HHS has put on digit…

AI Summary: The federal Trusted Exchange Framework and Common Agreement (TEFCA) has passed roughly 500 million health records exchanged across participating networks, a milestone officials say will accelerate interoperability and data flow. The milestone spotlights rapid uptake and complementary data initiatives—plus the governance and privacy work that now comes with scale.

#healthcare #publichealth #governmentpolicy #digitalhealth

3 months / oncodaily

3 months / fiercehealthcare


Back to Top / Friday, February 13, 2026, 12:22 pm / permalink 19136 / 4 stories in 3 months /

Back to Top


PUBLICHEALTH Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 300

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Animal Health, Supply Chain, Hospital Operations, Vitamin D and look for the RSS link.


NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.